
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Felbamate Related Compound B (Phenethyl carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C9H11NO2Color and Shape:White Crystalline PowderMolecular weight:165.07898Betamethasone Dipropionate Related Compound C (9-Fluoro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C25H33FO6Color and Shape:White PowderMolecular weight:448.53Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H12N2O2Color and Shape:White Off-White SolidMolecular weight:192.08988Mesna Related Compound B (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride)
Organo-sulfur compounds, nesoiFormula:C4H8K2O6S4·NaClColor and Shape:White PowderMolecular weight:415.80641Methylprednisolone Hemisuccinate Related Compound B (11β,21-Dihydroxy-6α-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen succinate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C26H34O8Color and Shape:White SolidMolecular weight:474.22537Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C22H32N2O4Color and Shape:White SolidMolecular weight:388.23621Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFormula:C6H15NColor and Shape:Clear Colorless LiquidMolecular weight:101.12045Mebendazole Related Compound D (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H15N3O3Color and Shape:SolidMolecular weight:309.32Azelastine Related Compound D (4-(4-chlorobenzyl)phthalazin-1(2H)-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C15H11ClN2OColor and Shape:White PowderMolecular weight:270.05599Amitriptyline Related Compound A (dibenzosuberone)
CAS:Aromatic ketones without other oxygen function, nesoiFormula:C15H12OColor and Shape:Pale Yellow PowderMolecular weight:208.26p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C24H33N3O4Color and Shape:White PowderMolecular weight:427.24711Irinotecan Related Compound B ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormula:C22H20N2O5Color and Shape:Yellow Off-White PowderMolecular weight:392.13722Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)
CAS:Other quinonesFormula:C12H16O2Color and Shape:Yellow LiquidMolecular weight:192.11503Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H29N7O3·C7H8O3SColor and Shape:White Yellow PowderMolecular weight:671.2526Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFormula:C7H6F3NColor and Shape:White Light Yellow LiquidMolecular weight:161.04523Cloxacillin Related Compound D (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H8ClNO3Color and Shape:PowderMolecular weight:237.64Lacosamide S-Enantiomer ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C13H18N2O3Color and Shape:White PowderMolecular weight:250.13174Dantrolene Related Compound C (5-(4-Nitrophenyl)furan-2-carbaldehyde)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormula:C11H7NO4Color and Shape:Yellow Crystalline PowderMolecular weight:217.03751Desflurane Related Compound A (Bis-(1,2,2,2-tetrafluoroethyl)ether)
CAS:Ethers of monohydric alcohols, nesoiFormula:C4H2F8OColor and Shape:Colorless LiquidMolecular weight:217.99779Dopamine Related Compound C (2-(3,4-Dimethoxyphenyl)ethan-1-amine)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormula:C10H15NO2Color and Shape:Yellow Brown LiquidMolecular weight:181.11028

